期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

树突状细胞疫苗的研究进展 被引量：2

下载PDF
导出
作者 赵峰 周清华
机构地区 四川省重点实验室四川大学华西医院肺癌分子实验室、胸心外科 华中科技大学同济医学院附属协和医院
出处 《中国肺癌杂志》 CAS 2003年第3期245-248,共4页 Chinese Journal of Lung Cancer
基金 国家自然科学基金 (30 0 0 0 2 0 6) 高等学校博士点基金 (2 0 0 0 55)
关键词 树突状细胞疫苗 生物学 DC 抗原递呈细胞 APC 肿瘤 免疫学
分类号 R392 [医药卫生—免疫学]
  • 相关文献

参考文献54

  • 1[1]Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med,1973,137(5)∶1142-1162.
  • 2[2]Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med,1992,176(6)∶1693-1702.
  • 3[3]Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med,1994,179(4)∶1109-1118.
  • 4[4]Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood,1997,90(9)∶3245-3287.
  • 5[5]Bancherean J and Steinma RM. Dendritic cells and the control of immunity. Nature,1998,392(6673)∶245-252.
  • 6[6]Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function ofdendritic cells. Curr Opin Immunol,1997,9(1)∶10-16.
  • 7[7]Strobl H, Bello-Fernandez C, Riedl E, et al. flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood,1997,90(4)∶1425-1434.
  • 8[8]Thurnher M, Papesh C, Ramoner R, et al. In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy. Exp Hematol,1997,25(3)∶232-237.
  • 9[9]Fields RC, Osterholzer JJ, Fuller JA, et al. Comparative analysis of murine dendritic cells derived from spleen and bone marrow. J Immunother,1998,21(5)∶323-339.
  • 10[10]Petty RE, Hunt DW. Neonatal dendritic cells. Vaccine,1998,16(14-15)∶1378-1382.

二级参考文献4

  • 1Banchereau J,Steinman RM.Dendritic cells and the control of immunity[].Nature.1998
  • 2Inaba K,Inaba M,Romani N,et al.Generation of large number of dendritic cells from mouse bone marrow cultures supplemented with GM-CSF[].The Journal of Experimental Medicine.1992
  • 3Abrams SI,Hand PH,Tsang KY,et al.Mutant ras epitopes as targets for cancer vaccines[].Seminars in Oncology.1996
  • 4Rosenberg SA.A new era for cancer immunotherapy based on the genes that encode cancer antigens[].Immunity.1999

共引文献7

同被引文献26

  • 1周清华,孙芝琳,覃扬,赵建升,伍伫.肺癌病人Ki－ras基因点突变与术后长期生存关系的研究[J].中国胸心血管外科临床杂志,1994,1(2):66-67. 被引量：6
  • 2Fernandez NC, Lozier A, Flament C, et al. Dendritic cells directly trigger NK cell functions: croos-talk relevant in innate anti - tumor immune responses in vivo[ J]. Nat Med, 1999,5:405 - 411.
  • 3Chen SR, Akbar SMF,Tanimoto K, et al. Absence of CD83 positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma relevance to hepatocarcinogenesis[ J]. Cancer Letters,2000. 148:49 - 57.
  • 4Mackensen A, Herbst B, Che JL, et al. Phase I study in melanima patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34( + )hematopoietic progenitor cells [ J]. Int J Cancer, 2000,86(3) :358 - 392.
  • 5Krause SW,Neumann C,Soruri A, et al. The treatment of patients with disseminated matignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells [ J ]. Journal of Immunotherapy,2002,25(5) :421 - 428.
  • 6Morse MA, Coleman RE, Akabani G, et al. Migration of human dendritic cells after injection in patients with metastatic malignancies[ J]. Cancer Res, 1999,59(1) :56 - 58.
  • 7Tfiozzi PL, Khurram R, Aldrich WA, et al. Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer[ J] . Cancer,2000,89 (12) : 2646 - 2654.
  • 8Fong L, Brockstedt D, Benike C, et al. Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy[ J]. J Immunol, 2001,167(12) :7150 - 7156.
  • 9Morisaki T, Matsumoto K, Onishi H, et al. Dendritic cell-based combind immunotherapy with autolgous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives[ J]. Human Cell, 2003,16(4) : 175 - 182.
  • 10Thurnet B, Haendle I, Roder C, et al. Vaccination with mage-3 Al peptide-pulsed mature monocle-derived dendritic cells expands specific cytotoxic T cells and induses regression of some metastases in advanced stage IV melanoma[ J]. J Exp Med, 1999,190( 11 ) : 1669 - 1678.

引证文献2

二级引证文献7

中国肺癌杂志
2003年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部